Compound Detail
CHEMBL149530
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL149530 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | SLYHWYGJPHJCOK-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
313.8
MW (Da)
2.56
ALogP
5
HBA
0
HBD
65.4
PSA (Ų)
0.81
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 4.57
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| MT4 CHEMBL388 | EC50 | 4.57 | 4.57 | 27000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| MT4 | EC50 | = | 27000.0 | nM | 4.57 | Effective concentration against HIV-1 induced cytopathogenicity in MT-4 cells | 8558522 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 8558522 | 10.1021/jm950568w | MT4 | 3 |
Data from ChEMBL 36 via Core Engine